Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ototoxic Hearing Loss”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableUnknownNCT05633719
What this trial is testing

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Who this might be right for
Solid Tumor, Childhood
Seoul National University Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT05129748
What this trial is testing

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 92
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Not applicableStudy completedNCT03400709
What this trial is testing

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Who this might be right for
Cisplatin Adverse ReactionHearing Loss Ototoxic
Hospital San Juan de Dios, Santiago 45
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Not applicableStudy completedNCT06036407
What this trial is testing

Screening for Hearing Loss After Childhood Cancer

Who this might be right for
Childhood CancerHearing Loss
University of Bern 476
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Not applicableLooking for participantsNCT06885411
What this trial is testing

Ototoxicity in Patients With MoM Hip Bearings

Who this might be right for
Ototoxic Hearing LossCobalt PoisoningChromium Causing Toxic Effect+1 more
Reinier Haga Orthopedisch Centrum 200
Testing effectiveness (Phase 2)Study completedNCT04766853
What this trial is testing

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Who this might be right for
Hearing Loss, SuddenHearing Loss, OtotoxicHearing Loss, Noise-Induced+1 more
Seoul National University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT05628233
What this trial is testing

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Who this might be right for
Hearing Loss Ototoxic
Sensorion 48